Effect of indomethacin on the binding of the chemotactic peptide formyl‐Met—Leu—Phe on human polymorphonuclear leukocytes
- 14 September 1981
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 132 (1) , 85-88
- https://doi.org/10.1016/0014-5793(81)80433-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prostaglandins, Arachidonic Acid, and InflammationScience, 1980
- Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.Journal of Clinical Investigation, 1980
- Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophilsBiochemical Pharmacology, 1980
- Cryptic receptors for chemotactic peptides in rabbit neutrophilsBiochemical and Biophysical Research Communications, 1980
- On the mechanism of human polymorphonuclear leukocyte deactivation of chemotaxis by the synthetic peptide formyl-methionyl-leucyl-phenylalanineFEBS Letters, 1980
- Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytesBiochemical Pharmacology, 1980
- Inhibition of the neutrophil oxidative response to A chemotactic peptide by inhibitors of arachidonic acid oxygenationBiochemical and Biophysical Research Communications, 1979
- Demonstration of a receptor on rabbit neutrophils for chemotactic peptidesBiochemical and Biophysical Research Communications, 1977
- Inhibition of Prostaglandin BiosynthesisPublished by Springer Nature ,1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973